Bluejay Diagnostics, Inc.
BJDX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $2,386 | $598 | $780 |
| - Cash | $3,082 | $4,443 | $3,116 | $4,302 |
| + Debt | $0 | $165 | $187 | $222 |
| Enterprise Value | – | -$1,892 | -$2,331 | -$3,299 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$1,587 | -$1,918 | -$1,837 | -$1,394 |
| % Margin | – | – | – | – |
| Net Income | -$1,598 | -$1,957 | -$1,864 | -$1,432 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.01 | -1.41 | -11.64 | -8.94 |
| % Growth | 28.4% | 87.9% | -30.2% | – |
| Operating Cash Flow | -$1,360 | -$2,054 | -$1,185 | -$1,739 |
| Capital Expenditures | $0 | $0 | $0 | -$1 |
| Free Cash Flow | -$1,360 | -$2,054 | -$1,185 | -$1,740 |